A Knowledge Hub
Concord Biotech in the News
Concord Biotech commercialises Amphotericin B (API)
Concord Biotech commercialises Amphotericin B (API).
Concord Biotech manufactures niche fermentation based Biotechnology company, manufacturing. API’s across various therapeutics segment like Immunosuppressants, Oncology, Anti-infective & antifungals and supplies to global pharmaceutical companies.